Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drugJulie Guillermet‐Guibert, Corinne Bousquet, Christiane Susini et al.|Molecular Cancer Therapeutics|2009Cited by 139
Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosisJulie Guillermet‐Guibert, Corinne Bousquet, Philippe Rochaix et al.|Proceedings of the National Academy of Sciences|2002Cited by 124
sst2 Somatostatin Receptor Mediates Negative Regulation of Insulin Receptor Signaling through the Tyrosine Phosphatase SHP-1Corinne Bousquet, Christiane Susini, Jean‐Pierre Estève et al.|Journal of Biological Chemistry|1998Cited by 113
Direct binding of p85 to sst2 somatostatin receptor reveals a novel mechanism for inhibiting PI3K pathwayCorinne Bousquet, Christiane Susini, Julie Guillermet‐Guibert et al.|The EMBO Journal|2006Cited by 84
Novel synergistic mechanism for sst2 somatostatin and TNFα receptors to induce apoptosis: crosstalk between NF-κB and JNK pathwaysJulie Guillermet‐Guibert, Corinne Bousquet, Nathalie Saint‐Laurent et al.|Cell Death and Differentiation|2006Cited by 50